Group One Trading, L.P. Navidea Biopharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$0.08 - $0.29 $24 - $87	300 New	300 $0
Q3 2022 Nov 09, 2022	SELL	$0.24 - $0.71 $8,808 - $26,057	-36,700 Reduced 16.14%	190,752 $48,000
Q2 2022 Aug 11, 2022	BUY	$0.63 - $1.1 $4,631 - $8,087	7,352 Added 3.34%	227,452 $164,000
Q1 2022 May 12, 2022	BUY	$0.72 - $1.2 $45,144 - $75,240	62,700 Added 39.83%	220,100 $174,000
Q4 2021 Feb 11, 2022	BUY	$1.0 - $1.82 $147,713 - $268,837	147,713 Added 1524.86%	157,400 $157,000
Q3 2021 Nov 12, 2021	BUY	$1.53 - $1.85 $13,766 - $16,646	8,998 Added 1305.95%	9,687 $17,000
Q2 2021 Aug 10, 2021	SELL	$1.55 - $2.15 $43,113 - $59,802	-27,815 Reduced 97.58%	689 $1,000
Q1 2021 May 12, 2021	BUY	$1.99 - $2.9 $19,593 - $28,553	9,846 Added 52.77%	28,504 $58,000
Q4 2020 Feb 10, 2021	SELL	$1.88 - $2.84 $7,888 - $11,916	-4,196 Reduced 18.36%	18,658 $40,000
Q3 2020 Nov 12, 2020	BUY	$2.69 - $4.95 $2,969 - $5,464	1,104 Added 5.08%	22,854 $62,000
Q2 2020 Aug 13, 2020	BUY	$0.7 - $4.16 $15,224 - $90,480	21,750 New	21,750 $86,000
Q1 2020 May 13, 2020	SELL	$0.76 - $1.54 $22,684 - $45,965	-29,848 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$0.65 - $1.26 $4,254 - $8,246	6,545 Added 28.09%	29,848 $38,000
Q3 2019 Nov 12, 2019	BUY	$0.5 - $0.91 $9,701 - $17,656	19,403 Added 497.51%	23,303 $16,000
Q2 2019 Aug 09, 2019	BUY	$0.62 - $3.6 $2,418 - $14,040	3,900 New	3,900 $2,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.